SLIT: Implementation in Your Practice
  • CE: 1.50
  • CME: 1.25
  • Course opens: Thu, May 01 2014
  • Course expires: Sat, Apr 30 2016
  • Non-member Cost: $0.00

Now that the FDA has approved the first sublingual immunotherapy (SLIT) products for use in the United States, allergist/immunologists have new options to consider when treating their patients who could benefit from allergen immunotherapy. This presentation - a recording of a symposium presented at the 2014 AAAAI Annual Meeting - provides an overview of the mechanisms of SLIT, a summary of the results of clinical trials with these new forms of immunotherapy, and a discussion of how to incorporate the administration of SLIT into an allergy/immunology practice.

Learning objectives

  1. Review how SLIT works.
  2. Discuss the results of pivotal SLIT clinical trials.
  3. Describe how to use SLIT in practice.

Target audience

Allergist/Immunologists

Allied Health Professionals working in allergy/immunology practices

Please log in or register to take this Course.

Do you want to enroll in this course?